Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1772 (LINC01772) is a member of the long non-coding RNA (lncRNA) family, specifically classified as a long intergenic non-coding RNA (lincRNA)[1][3][5]. LINC01772 does not encode a protein and does not overlap with annotated protein-coding genes. Rather, like other lincRNAs, it is involved in various forms of gene regulation, such as chromatin remodeling and transcriptional control. Some lincRNAs serve as enhancers or regulate the activity of neighboring or distant genes via both sequence-dependent and sequence-independent mechanisms. While the general class of lincRNAs has been linked to tissue-specific gene regulation, chromatin structure alterations, and disease processes, there are currently no validated reports on specific biological, pathological, or clinical roles for LINC01772[1][3][5]. No drugs are known to target this RNA, and it is not considered a therapeutic target at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1772 (LINC01772).